PROANTHOCYANIDINS IMPROVE CELLULAR MITOCHONDRIAL DYSFUNCTION BY REGULATING MITOPHAGY IN SH-SY5Y CELLS

ZHANG Mei-rong, ZHANG Xiao-qiang, ZHANG Xiu-wen, DING Lan, YU Qi-jia

Acta Nutrimenta Sinica ›› 2024, Vol. 46 ›› Issue (6) : 599-605.

Acta Nutrimenta Sinica ›› 2024, Vol. 46 ›› Issue (6) : 599-605.
ORIGINAL ARTICLES

PROANTHOCYANIDINS IMPROVE CELLULAR MITOCHONDRIAL DYSFUNCTION BY REGULATING MITOPHAGY IN SH-SY5Y CELLS

  • ZHANG Mei-rong1,2, ZHANG Xiao-qiang1,2, ZHANG Xiu-wen1,2, DING Lan1,2, YU Qi-jia1,2
Author information +
History +

Abstract

Objective To explore the mechanism of proanthocyanidins (PAC) in protecting against mitochondrial damage induced by N-methyl-4-phenylpyridinium iodide (MPP+) in SH-SY5Y cells. Methods SH-SY5Y cells were treated with MPP+ to establish an in vitro model of Parkinson's disease. The cells were randomly divided into control group, MPP+ group, PAC group, PAC + MPP+ group, 3-MA group, and 3-MA + PAC+ MPP+ group. Cell viability was assessed by the MTT method, ROS generation was measured by a chemical fluorescence method. JC-1 was used to detect mitochondrial membrane potential levels. Intracellular ATP content was determined by the molybdenum blue colorimetric method. The expression of mitochondrial autophagy-related proteins was detected by Western blot. Results Compared to the control group, treatment with MPP+ significantly reduced the viability of SH-SY5Y cells, and led to a significant increase in the accumulation of ROS, and significantly decreased ATP levels. Furthermore, compared to the control group, MPP+ treatment resulted in the decreases of cellular mitochondrial membrane potential, increased expression levels of the P62 protein, reduced expression levels of PHB2 proteins, and decreased ratio of LC3-II/LC3I. Treatment of SH-SY5Y cells with PAC was able to significantly reduce intracellular ROS accumulation induced by MPP+, increase ATP level, decrease the expression level of P62 protein, increase the expression level of PHB2 protein, and enhance the LC3-II/LC3I ratio. However, compared with the PAC+MPP+ group, the pre-treatment with 3-MA significantly reduced the protective effects of PAC on MPP+-induced mitochondrial damage in SH-SY5Y cells. Conclusion PAC may alleviate mitochondrial dysfunction induced by MPP+ through the mitophagy.

Key words

proanthocyanidins / mitochondria / autophagy / SH-SY5Y cells

Cite this article

Download Citations
ZHANG Mei-rong, ZHANG Xiao-qiang, ZHANG Xiu-wen, DING Lan, YU Qi-jia. PROANTHOCYANIDINS IMPROVE CELLULAR MITOCHONDRIAL DYSFUNCTION BY REGULATING MITOPHAGY IN SH-SY5Y CELLS[J]. Acta Nutrimenta Sinica. 2024, 46(6): 599-605

References

[1] Vastegani SM, Nasrolahi A, Ghaderi S, et al. Mitochon-drial dysfunction and Parkinson’s disease: pathogenesis and therapeutic strategies[J]. Neurochem Res, 2023, 48: 2285–2308.
[2] Clark EH, Torre AV De La, Hoshikawa T, et al. Targeting mitophagy in Parkinson’s disease[J]. J Biol Chem, 2021, 296:100209.
[3] Haddad D, Nakamura K.Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson’s disease[J]. FEBS Lett, 2015, 589:3702–3713.
[4] Dias V, Junn E, Mouradian MM.The role of oxidative stress in Parkinson’s disease[J]. J Parkinsons Dis, 2013, 3: 461–491.
[5] Dong X, He X, Yang L, et al. Inhibition of miR-421 preserves mitochondrial function and protects against Parkinson’s disease pathogenesis via PINK1/Parkin-dependent mitophagy[J]. Dis Markers, 2022, 2022: 5186252.
[6] Langston JW, Ballard P, Tetrud JW, et al. Chronic parkinsonism in humans due to a product of meperidine- analog synthesis[J]. Science, 1983, 219: 979–980.
[7] Dauer W, Przedborski S.Parkinson’s disease: mechanisms and models[J]. Neuron, 2003, 39: 889–909.
[8] Shi Y, Tao M, Ma X, et al. Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathy[J]. Cell Death Dis, 2020, 11: 467.
[9] Terra X, Fernández-Larrea J, Pujadas G, et al. Inhibitory effects of grape seed procyanidins on foam cell formation in vitro[J]. J Agric Food Chem, 2009, 57: 2588–2594.
[10] Chen J, Chen Y, Zheng Y, et al. Protective effects and mechanisms of procyanidins on Parkinson’s disease in vivo and in vitro[J]. Molecules, 2021, 26: 5558.
[11] Yang X, Liu T, Chen B, et al. Grape seed proanthocya-nidins prevent irradiation-induced differentiation of human lung fibroblasts by ameliorating mitochondrial dysfunction[J]. Sci Rep, 2017, 7: 62.
[12] Chen H, Xu J, Lv Y, et al. Proanthocyanidins exert a neuroprotective effect via ROS/JNK signaling in MPTP-induced Parkinson’s disease models in vitro and in vivo[J]. Mol Med Rep, 2018, 18: 4913–4921.
[13] Xu Q, Chen Z, Zhu B, et al. Neuroprotective effects of b-type cinnamon procyanidin oligomers on MPP+-induced apoptosis in a cell culture model of Parkinson’s disease[J]. Molecules, 2021, 26: 6422.
[14] Strathearn KE, Yousef GG, Grace MH, et al. Neuropro-tective effects of anthocyanin- and proanthocyanidin- rich extracts in cellular models of Parkinson's disease[J]. Brain Res, 2014, 1555: 60–77.
[15] Ding Y, Xin C, Zhang CW, et al. Natural molecules from Chinese herbs protecting against Parkinson’s disease via anti-oxidative stress[J]. Front Aging Neurosci, 2018, 10: 246.
[16] Basli A, Soulet S, Chaher N, et al. Wine polyphenols: potential agents in neuroprotection[J]. Oxid Med Cell Longev, 2012, 2012:805762.
[17] Mnatsakanyan N, Jonas EA.The new role of F1Fo ATP synthase in mitochondria-mediated neurodegeneration and neuroprotection[J]. Exp Neurol, 2020, 332: 113400.
[18] Connelly EM, Frankel KS, Shaw GS.Parkin and mitochondrial signalling[J]. Cell Signal, 2023, 106: 110631.
[19] Nallathambi R, Poulev A, Zuk JB, et al. Proanthocya-nidin-rich grape seed extract reduces inflammation and oxidative stress and restores tight junction barrier function in Caco-2 colon cells[J]. Nutrients, 2020, 12: 1623.
[20] Liu K, Li W, Yuen M, et al. Sea buckthorn proanthocya-nidins are the protective agent of mitochondrial function in macrophages under oxidative stress[J]. Front Pharmacol, 2022, 13:914146.
[21] Dorszewska J, Kowalska M, Prendecki M, et al. Oxidative stress factors in Parkinson’s disease[J]. Neural Regen Res, 2021, 16: 1383-1391.
[22] Guo JD, Zhao X, Li Y, et al. Damage to dopaminergic neurons by oxidative stress in Parkinson’s disease (review)[J]. Int J Mol Med, 2018, 41: 1817–1825.
[23] Puspita L, Chung SY, Shim JW.Oxidative stress and cellular pathologies in Parkinson’s disease[J]. Mol Brain, 2017, 10: 53.
[24] He R, Jiang Y, Shi Y, et al. Curcumin-laden exosomes target ischemic brain tissue and alleviate cerebral ischemia-reperfusion injury by inhibiting ROS-mediated mitochondrial apoptosis[J]. Mater Sci Eng C Mater Biol Appl, 2020, 117: 111314.
[25] Jiang DQ, Zang QM, Jiang LL, et al. SIRT3 expression alleviates microglia activation-induced dopaminergic neuron injury through the mitochondrial pathway[J]. Exp Ther Med, 2022, 24: 662.
[26] Ottaviani JI, Heiss C, Spencer JPE, et al. Recommending flavanols and procyanidins for cardiovascular health: revisited[J]. Mol Aspects Med, 2018, 61: 63–75.
[27] Gong YS, Guo J, Hu K, et al. Ameliorative effect of lotus seedpod proanthocyanidins on cognitive impairment and brain aging induced by D-galactose[J]. Exp Gerontol, 2016, 74: 21–28.
[28] Nicolosi R M, Bonincontro G, Imperia E, et al. Protective effect of procyanidin-rich grape seed extract against gram-negative virulence factors[J]. Antibiotics (Basel), 2023, 12: 1615.
[29] Hu Z, Wen T, Hu K, et al. Transcutaneous electrical acupoint stimulation ameliorates cognitive function through PINK1/Parkin mediated mitophagy in VD rats[J]. Evid Based Complement Alternat Med, 2022, 2022: 2810794.
[30] Jiao K, Lai Z, Cheng Q, et al. Glycosides of Buyang Huanwu decoction inhibits inflammation associated with cerebral ischemia-reperfusion via the PINK1/Parkin mitophagy pathway[J]. J Ethnopharmacol, 2024, 325: 117766.
[31] Li J, Yang D, Li Z, et al. PINK1/Parkin-mediated mitophagy in neurodegenerative diseases[J]. Ageing Res Rev, 2023, 84: 101817.
[32] Xu W, Ocak U, Gao L, et al. Selective autophagy as a therapeutic target for neurological diseases[J]. Cell Mol Life Sci, 2021, 78: 1369–1392.
[33] Wei Y, Chiang WC, Sumpter R Jr, ,et al. Prohibitin 2 is an inner mitochondrial membrane mitophagy receptor[J]. Cell. Prohibitin 2 is an inner mitochondrial membrane mitophagy receptor[J]. Cell, 2017, 168: 224-238.e10.
[34] Sun S, Hou H, Ma G, et al. The interaction between E3 ubiquitin ligase Parkin and mitophagy receptor PHB2 links inner mitochondrial membrane ubiquitination to efficient mitophagy[J]. J Biol Chem, 2022, 298: 102704.
[35] Wei MF, Kuo SH.Inhibition of SOX9 may be an effective target for increasing radiosensitivity in gastrointes-tinal cancer[J]. Ann Transl Med, 2017, 5(10):224.
[36] Deng YN, Shi J, Liu J, et al. Celastrol protects human neuroblastoma SH-SY5Y cells from rotenone-induced injury through induction of autophagy[J]. Neurochem Int, 2013, 63: 1–9.
[37] Guo S, Qi M, Li H, et al. The protective effect of Lycium ruthenicum Murr anthocyanins in Cr (VI)-induced mitophagy in DF-1 cells[J]. Life (Basel), 2022, 12: 1115.

Accesses

Citation

Detail

Sections
Recommended

/